GlycoVaxyn
discovers, develops and manufactures next-generation bioconjugate vaccines... Read moreGlycoVaxyn
discovers, develops and manufactures next-generation bioconjugate vaccines... Read more
CEO
Philippe Dro
News
Sep 03, 2015
FIERCE PHARMA
GlycoVaxyn: GSK inks exclusive vaccines deal with new GlycoVaxyn affiliate
Sep 03, 2015
FIERCE BIOTECH
GlycoVaxyn: LimmaTech sets up as de facto GSK vaccine R&D unit in wake of $190M buyout
Aug 28, 2015
BIOPORTFOLIO
GlycoVaxyn: GlycoVaxyns research spinout LimmaTech starts operations
Jun 01, 2015
PR-INSIDE.COM
Press Release: GlycoVaxyn : New Market Research Report: GlycoVaxyn AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
May 27, 2015
BUSINESS WIRE
Press Release: GlycoVaxyn : Research and Markets: Streptococcus Pyogenes Infections - Pipeline Review, H1 2015
May 14, 2015
BUSINESS WIRE
Press Release: GlycoVaxyn : Research and Markets: Global Shigella Infections (Shigellosis) Pipeline Report 2015
Feb 17, 2015
BIOPORTFOLIO
GlycoVaxyn: GlycoVaxyn AG sells its shares to GSK
Feb 12, 2015
BUSINESS ETC
GlycoVaxyn: GlaxoSmithKline plc (ADR) Acquires Vaccine Maker GlycoVaxyn For $190 Million
Feb 12, 2015
PHARMACEUTICAL BUSINESS REVIEW
GlycoVaxyn: GlaxoSmithKline acquires remaining stake in Glycovaxyn for $190m
Feb 11, 2015
BIOPORTFOLIO
GlycoVaxyn: UPDATE GSK acquires remainder of GlycoVaxyn for $190 million
GlycoVaxyn Competitors
1
2
3
4
5
6